Cancer disease describes any pathology involving uncontrolled cell growth. As cells
duplicate, they can remain localized in defined tissues, forming tumor masses and altering …

This systematic review and meta-analysis provides epidemiological data on the relationship
between chronic inflammation, as measured by inflammatory blood parameters, and cancer …

Background Nivolumab offers a superior survival benefit over docetaxel in patients with
advanced, previously treated non-small-cell lung cancer (NSCLC). An association between …

Background: Factors contributing to chronic inflammation appear to be associated with
increased risk of ovarian cancer. The purpose of this study was to assess the association …

Background: High-sensitivity C-reactive protein (hs-CRP) is a commonly used inflammatory
marker. The association between hs-CRP and cancer is less consistent than that between …

Objective Pro-inflammatory mechanisms may explain the increased ovarian cancer risk
linked to more lifetime ovulations, endometriosis, and exposure to talc and asbestos, as well …

In order to discover potential glycoprotein biomarkers in ovarian cancer, we applied a lectin
array and Exactag labeling based quantitative glycoproteomics approach. A lectin array …

Growing epidemiologic evidence supports chronic inflammation as a mechanism of ovarian
carcinogenesis. An association between a circulating marker of inflammation, C-reactive …

Chronic inflammation may play a role in ovarian carcinogenesis. We examined associations
between 3 plasma biomarkers of inflammation—C-reactive protein (CRP), interleukin 6, and …

Ovarian cancer is the most fatal gynecologic cancer and is an important source of cancer-
related mortality, particularly in developed countries. Despite substantial research …